SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novartis BidCo Germany AG(100.00%),Novartis BidCo AG(100.00%), etc.
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novartis BidCo Germany AG(94.55%),Novartis BidCo AG(94.55%), etc.
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novartis BidCo Germany AG(91.17%),Novartis BidCo AG(91.17%), etc.
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novartis BidCo AG(91.17%),Novartis Pharma AG(91.17%), etc.
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novartis BidCo AG(89.47%),Novartis Pharma AG(89.47%), etc.
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novartis BidCo AG(79.58%),Novartis Pharma AG(79.58%), etc.
SC 13D: Statement of acquisition of beneficial ownership by individuals-Novartis BidCo AG(11.56%),Novartis Pharma AG(11.56%), etc.
Novartis AG | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(6.1%)
Novartis AG | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(5.4%)
Novartis AG | 3: Initial statement of beneficial ownership of securities-10% Owner NOVARTIS PHARMA AG
Novartis AG | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.7%)
Novartis AG | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Novartis AG | 3: Initial statement of beneficial ownership of securities
Novartis AG | 4: Statement of changes in beneficial ownership of securities
Novartis AG | 3: Initial statement of beneficial ownership of securities
Novartis AG | 4: Statement of changes in beneficial ownership of securities
Novartis AG | 3: Initial statement of beneficial ownership of securities
Novartis AG | 4: Statement of changes in beneficial ownership of securities
Novartis AG | 3: Initial statement of beneficial ownership of securities
Novartis AG | 4: Statement of changes in beneficial ownership of securities